Tools
Stock profile

SMITH & NEPHEW PLC (SNN)

SNN · Latest close $30.32 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$30.32
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

SMITH & NEPHEW PLC (SNN) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Latest close $30.32 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Causeway Capital Management — 1 tracked fund hold SNN. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Causeway Capital Management0.49%1,565,167ADDED (+64.2%) Q3 filed Nov 13
Saturna Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +6.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

38.7023.302024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding293 of 8,857 filers
Long-only filers among them293
Change vs 2026 Q1+18 net · 284 entered · 266 exited
Shares reported, all filers36,521,876
Reported value, all filers$1.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Net income · FY2025$625.0M
Total assets · FY2025$10.5B
Shares outstanding877,724,845
Market cap (at latest close)$26.6B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.

Short interest

Shares short · Oct 15, 20264,040,249
Share of shares outstanding0.46%
Days to cover3.12

Shares short at recent settlements — Jul 31, 2026: 5.1M · Aug 14, 2026: 4.9M · Aug 31, 2026: 6.2M · Sep 15, 2026: 4.8M · Sep 30, 2026: 4.7M · Oct 15, 2026: 4.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.

Fails to deliver

Shares failed to deliver · Oct 14, 202613,987
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.3%

Fails to deliver at recent settlements — Jul 31, 2026: 51K · Aug 14, 2026: 62K · Aug 31, 2026: 8K · Sep 15, 2026: 0 · Sep 30, 2026: 15K · Oct 14, 2026: 14K.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Jul 27, 2026SCHEDULE 13D/A-6.3% (close Jul 28, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Jul 28, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Jul 27, 2026Cevian Capital II GP LimitedSC 13D/A119,179,41914.2%Jul 23, 2026SEC filing
Jun 24, 2026Cevian Capital II GP LimitedSC 13D/A110,804,50113.1%Jun 22, 2026SEC filing
Jun 3, 2026Cevian Capital II GP LTDSC 13D/A101,046,78811.9%Jun 1, 2026SEC filing
May 4, 2026Cevian Capital II GP LTDSC 13D/A91,462,09510.7%Apr 30, 2026SEC filing
Mar 16, 2026Cevian Capital II GP LTDSC 13D/A81,687,1369.6%Mar 12, 2026SEC filing
Jun 16, 2025Cevian Capital II GP LimitedSC 13D/A74,469,9258.5%Jun 12, 2025SEC filing
Apr 23, 2025BlackRock, Inc.SC 13G/A63,497,7437.3%Mar 31, 2025SEC filing
Feb 19, 2025Cevian Capital II GP LimitedSC 13D/A65,480,2547.5%Feb 14, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: no Lobbying Disclosure Act filings matched for this ticker (1999–2026).

Federal contracts: $4.7M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$520.0K
FY2022$1.8M
FY2023$1.9M
FY2024$568.0K
FY2025$0
FY2026$0

Largest awards collected

Award IDAgencyAmountStart
36C26120P1246Department of Veterans Affairs$609.8KSep 21, 2020
36C26122P0730Department of Veterans Affairs$375.0KApr 11, 2022
HT001419F0212Department of Defense$293.2KFeb 13, 2019
36C25021N0339Department of Veterans Affairs$167.4KFeb 10, 2021
36C25720P1418Department of Veterans Affairs$164.9KSep 4, 2020

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

This stock does not currently pass any tracked screen.

Also held by the tracked funds that hold SNN — ranked by lift, the co-holding pattern described in Methodology: INTUITIVE SURGICAL INC (ISRG) · ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Edwards Lifesciences Corp (EW) · ESTABLISHMENT LABS HOLDINGS INC. (ESTA) · MSA Safety Inc (MSA) · STERIS plc (STE) · ALIGN TECHNOLOGY INC (ALGN) · Enovis CORP (ENOV).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

No Form 8-K filings for this ticker in the index (Jan 2023 – present).

Related

INTUITIVE SURGICAL INC (ISRG) · Track Record: how the signals scored · Practice timing on SNN

One email a week: the week’s new filings and research. Subscribe free

← SNEX  ·  SNOW →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.